PE anti-human α/β T Cell Receptor Antib
- 产品名称：
- PE anti-human α/β T Cell Receptor Antib
- 产品类别：
- 抗体
- 产品编号：
- 306707
- 产品应用：
- 306707
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1320 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: T cell activation. When co-staining with anti-CD3, we recommend using clone UCHT1, since we have confirmed that IP26 does not compete with this clone. ?Other anti-CD3 clones may compete out the binding of IP26. ?
- Application References
(PubMed link indicates BioLegend citation) -
- Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York. (FC)
- Joseph A, et al. 2008. J. Virol. 82:3078. (FC) PubMed
- Pinto JP, et al. 2010. Immunology. 130:217. PubMed
- Product Citations
-
- Renauer P, et al. 2015. Clin Immunol. 156:19. PubMed
- Frazzette N, et al. 2020. NPJ Precis Oncol. 4:13. PubMed
- Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
- Sibener LV et al. 2018. Cell. 174(3):672-687 . PubMed
- Jarrell JA, et al. 2021. Sci Rep. 11:11818. PubMed
- Hunter S, et al. 2018. J Hepatol. 69:654. PubMed
- Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
- Le J, et al. 2020. Immunity. 52(6):1105-1118.e9. PubMed
- Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
- Frazzette N, et al. 2020. NPJ Precis Oncol. 4:13. PubMed
- Chapman N, et al. 2013. J Immunol. 191:6208. PubMed
- Siegers G, et al. 2011. PLoS One. 6:e16700. PubMed
- Shan L, et al. 2017. Immunity. 47:766. PubMed
- RRID
- AB_314645 (BioLegend Cat. No. 306707) AB_314646 (BioLegend Cat. No. 306708)
